Health News Archive - September 18, 2008
HOPKINTON, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc., announced today that Cethrin has been granted designation as an orphan medicinal product for the treatment of traumatic spinal cord injury (SCI) by the European Commission.
Futuremed Healthcare Income Fund (TSX: FMD.UN) today announced the monthly cash distribution for September 2008 has been set at $0.0771 per unit, or $0.925 per unit on an annualized basis. The distribution will be paid on October 15, 2008, to unitholders of record as at September 30, 2008.
HORSHAM, Pa., Sept.
MIV Therapeutics, Inc. (OTCBB: MIVI, www.mivtherapeutics.com) CEO and President, Dr.
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A.
MONTVALE, N.J., Sept. 18 /PRNewswire/ -- Dowden Health Media announces OBG Management's 20 years of bringing obstetricians and gynecologists the knowledge to provide better care. With the September issue, OBG Management begins celebrating its 20th birthday and will be through September 2009.
PORTON DOWN, England, September 18 /PRNewswire/ -- Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics Company, announces that it has been awarded a grant of GBP1.8M from the UK Government's Technology Strategy Board under the "Technologies for Health" programme.
Radiation Medical Group, Inc. is the first center in the nation to use a new version of the SAVI applicator for radiation treatment of breast cancer, potentially expanding the number of women who will qualify for breast brachytherapy.
The Nevada health plan subsidiary of managed healthcare company Amerigroup has contracted with the State of Nevada to serve people enrolled in its Medicaid and State Children's Health Insurance programs, effective February 1, 2009.